Literature DB >> 16550917

Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.

T Endo1.   

Abstract

Dystroglycan is encoded by a single gene and is cleaved into two proteins, alpha- and beta-dystroglycan, by posttranslational processing. In skeletal muscle, dystroglycan is a component of the dystrophin-glycoprotein complex. alpha-Dystroglycan is an extracellular peripheral membrane glycoprotein that binds to beta-dystroglycan, which is a transmembrane glycoprotein. alpha-Dystroglycan is heavily glycosylated and its sugars have a role in binding to laminin, neurexin and agrin. The main glycan of alpha-dystroglycan was found to be O-mannosylglycan which is a ligand of laminin. We identified and characterized two glycosyltransferases involved in the biosynthesis of O-mannosylglycans. These two enzymes are responsible for congenital muscular dystrophies, muscle-eye-brain disease and Walker-Warburg syndrome. These results indicate that O-mannosylation of alpha-dystroglycan is important in muscle and brain development. This review describes the relation between aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16550917

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  6 in total

1.  A conserved acidic motif is crucial for enzymatic activity of protein O-mannosyltransferases.

Authors:  Mark Lommel; Andrea Schott; Thomas Jank; Verena Hofmann; Sabine Strahl
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

2.  GMPPA defects cause a neuromuscular disorder with α-dystroglycan hyperglycosylation.

Authors:  Patricia Franzka; Henriette Henze; M Juliane Jung; Svenja Caren Schüler; Sonnhild Mittag; Karina Biskup; Lutz Liebmann; Takfarinas Kentache; José Morales; Braulio Martínez; Istvan Katona; Tanja Herrmann; Antje-Kathrin Huebner; J Christopher Hennings; Susann Groth; Lennart Gresing; Rüdiger Horstkorte; Thorsten Marquardt; Joachim Weis; Christoph Kaether; Osvaldo M Mutchinick; Alessandro Ori; Otmar Huber; Véronique Blanchard; Julia von Maltzahn; Christian A Hübner
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

3.  Comparison of the substrate specificities and catalytic properties of the sister N-acetylglucosaminyltransferases, GnT-V and GnT-Vb (IX).

Authors:  Gerardo Alvarez-Manilla; Karolyn Troupe; Maria Fleming; Erika Martinez-Uribe; Michael Pierce
Journal:  Glycobiology       Date:  2009-10-21       Impact factor: 4.313

Review 4.  Glycosylation diseases: quo vadis?

Authors:  Harry Schachter; Hudson H Freeze
Journal:  Biochim Biophys Acta       Date:  2008-11-13

Review 5.  Dystroglycan glycosylation and its role in alpha-dystroglycanopathies.

Authors:  T Endo
Journal:  Acta Myol       Date:  2007-12

6.  Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study.

Authors:  Susan Sparks; Goran Rakocevic; Galen Joe; Irini Manoli; Joseph Shrader; Michael Harris-Love; Barbara Sonies; Carla Ciccone; Heidi Dorward; Donna Krasnewich; Marjan Huizing; Marinos C Dalakas; William A Gahl
Journal:  BMC Neurol       Date:  2007-01-29       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.